Skip to Main Content

An official website of the United States government

Here you can browse the complete list of projects on CDAS whose requests for data/biospecimens were approved.

Name Principal Investigator Institution Study Date Approved Project ID
Analysis the tumor character and clinical data hanae yoshida Hitachi,Ltd NLST Jan 8, 2021 NLST-740
CT Findings and Long-Term Mortaity from Respiratory Diseases Paul Pinsky NCI NLST Jan 8, 2021 NLST-750
Generalizing the effect of chest x-ray screening Jon Steingrimsson Brown University PLCO Dec 31, 2020 PLCO-707
Lung Nodule Detection and Benign and Malignant Diagnosis Based on Deep Learning zhengwen Ma Zhongshan Yangshi Technology Co., Ltd NLST Dec 31, 2020 NLST-746
Implication of new models for predicting lung cancer screening selection based on CT scan and pathology image data Yuan Luo Northwestern University NLST Dec 31, 2020 NLST-745
Implication of new models for predicting lung cancer screening selection based on CT scan and pathology image data Yuan Luo Northwestern University PLCO Dec 31, 2020 PLCO-710
Validation of Deep Learning Algorithm on Nodule Detection using Chest Radiographs in the National Lung Screening Trial Hao Wu Infervision Medical Technology NLST Dec 29, 2020 NLST-744
Automated Medical Diagnostic Systems Fabien Scalzo University of California, Los Angeles (UCLA) PLCO Dec 29, 2020 PLCO-711
Multi-label Classification to Hierarchical Taxonomies for Lung cai chen Qingdao University of Science and Technology PLCO Dec 22, 2020 PLCOI-704
Development of improved pre-diagnostic biomarker-based screening algorithms for ovarian cancer Anna Lokshin UPMC Hillman Cancer Center PLCO Dec 22, 2020 2020-1020
Delineating the underlying reasons for the racial disparity in gastric cancer incidence in the United States. Haejin In Rutgers Cancer Institute PLCO Dec 22, 2020 2020-1002
Perfluoroalkyl Substances (PFASs) and Liver Cancer Risk in the United States Xuehong Zhang Harvard Medical School and Brigham and Women's Hospital PLCO Dec 22, 2020 2020-1001
Updates in lethal prostate cancer in the PLCO trial Jonathan Shoag Weill Cornell Medicine PLCO Dec 21, 2020 PLCO-701
Convolutional Survival Machines: Deep Convolutional Networks for Survival Analysis with Time-Varying risks. Artur Dubrawski Carnegie Mellon University PLCO Dec 21, 2020 PLCOI-706
Diabetes, antidiabetic medication use, and the risk of ovarian cancer Susan Steck University of South Carolina PLCO Dec 21, 2020 PLCO-705
Artificial Intelligence To Predict The Risk Of Malignancy In Lung Cancer By Low-Dose CT Screening Studies Christian Salvatore DeepTrace Technologies, spin-off of University School for Advanced Studies IUSS Pavia NLST Dec 21, 2020 NLST-739
Convolutional Survival Machines: Deep Convolutional Networks for Survival Analysis with Time-Varying risks. Artur Dubrawski Carnegie Mellon University NLST Dec 21, 2020 NLST-738
Evaluation of a Lung Lesion Detection Tool Hajime Sasaki Hitachi Lyon Lab, Hitachi Medical Systems S.A.S. NLST Dec 18, 2020 NLST-736
Diabetes risk reduction diet and all-cause and cause-specific mortality in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Guo-Chao Zhong The Second Affiliated Hospital of Chongqing Medical University PLCO Dec 11, 2020 PLCO-700
Survival Analysis with Whole Slide Images based on Deep Learning Technique Lei Fan UNSW Sydney NLST Dec 11, 2020 NLST-734